Patent · US Active

Representative diagnostics

US11959838B2 · kind B2 · utility

1Cited by
63References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2018
Grant dateApr 16, 2024
Priority date
Expiry dateApr 27, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The disclosure generally relates to the preparation of representative samples from clinical samples, e.g., tumors (whole or in part), lymph nodes, metastases, cysts, polyps, or a combination or portion thereof, using mechanical and/or biochemical dissociation methods to homogenize intact samples or large portions thereof. The resulting homogenate provides the ability to obtain a correct representative sample despite spatial heterogeneity within the sample, increasing detection likelihood of low prevalence subclones, and is suitable for use in various diagnostic assays as well as the production of therapeutics, especially “personalized” anti-tumor vaccines or immune cell based therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.